Learning Objectives:

1. Review The Molecular genetics of Hypertrophic Cardiomyopathy (HCM)

2. Summarize The 2020 AHA/ACC Guidelines For Diagnosis And Treatment Of HCM

3. Appraise Myosin Inhibitors As A New Approach To Treating Obstructive Hypertrophic Cardiomyopathy (HOCM)

 

Faculty Disclosure:

Monica Ahluwalia, MD, Presenter has nothing to disclose

Faculty does not plan to discuss the uses of an investigational product. 

 

Session date: 
05/03/2023 - 12:00pm to 1:00pm EDT
Location: 
Boston Medical Center
72 E. Concord
Collamore-8
Boston, MA 02118
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™

    Boston University Chobanian & Avedisian School of Medicine designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 1.00 Participation
Please login or register to take this course.